Abstract
An Adverse Drug Reaction (ADRs) is still a challenge in modern healthcare, increasing complication of therapeutics, an elderly populace and increasing multimorbidity. Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem. This article is having objective of evaluating the pharmacist perception about Pharmacovigilance and ADRs monitoring through ample literature review. In India pharmacovigilance activity begins in 1986 with ADR monitoring system under supervision of drug controller general of India. The prescribed National Pharmacovigilance Program was commence in 2005; with unsuccessful attempt in 1998, and renamed as Pharmacovigilance Program of India (PvPI) in 2010. Adverse drug reactions monitoring has become an essential part to be executed together with other health-care services for a safe use of medicines. Pharmacist can play an important role in evaluation of ADRs. Pharmacist – drug expert- having abundant knowledge of pharmacological action, pharmaco-therapeutics, adverse reactions, and disease pathophysiology, can make the drug therapy safer.
Highlights
An Adverse Drug Reaction (ADRs) is still a challenge in modern healthcare, increasing complication of therapeutics, an elderly populace and increasing multimorbidity
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem
This article is having objective of evaluating the pharmacist perception about Pharmacovigilance and ADRs monitoring through ample literature review
Summary
It is a recognized truth that not a single drug is absolutely free from side effects. It is difficult to find out all possible, predictable and unpredictable ADRs in clinical trial studies. Pharmacovigilance program is useful for the identification of uncommon ADRs, which are escaped during the animal studies and clinical trials of the drugs. In India adverse drug reaction reporting authority is Indian Pharmacopoeia Commission (IPC). - 02 zonal centers – South-West (SW) zone and North-East (NE) zone These centers were responsible to collect information from pan India and process . Under these zonal centers there were regional subsequently peripheral centers are established [21]. In India there are various studies focuses on this research viz. Ghosh S, Leelavathi DA, Padma GM (2006), Chhetri AK et al (2008), Padmaja U et al (2009), Poddar S. et al (2009), Gupta P. et al (2011), Kristina SG et al (2011), Rajesh R, Vidyasagar S, nandkumar K (2011), Shrivastav M. et al (2011), Divakar B et al (2012), John IJ et al (2012), Rishi RK et al (2012), Smyth RMD et al (2012), Joshi N et al (2013), Lihite et al (a) (2013), Lihite et al (b) (2013), Lobo et al (2013), Mishra S et al (2013), Pintail BS (2013),Shi QP et al (2013), Vijaykumar, Dhanaraju (2013), Alam K et al (2014), Bhuvana KB et al (2014), Nirojini PS et al (2014), Shamna M et al (2014), Tads’ et al (2014), Roshani A et al (2015), Sharma A et al (2015) [15]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
